New Delhi, Sept. 28 -- The Supreme Court on Monday suggested that authorities explore unconventional measures to recover unpaid traffic challans, including adding the outstanding amount to electricity... Read More
New Delhi, Sept. 28 -- The Supreme Court on Monday reserved its judgement in the matter related to front-of-the-pack (FoPL) labelling regulations for the packaged food industry. The bench directed all... Read More
Hyderabad, Sept. 28 -- The All India Majlis-E-Ittehadul Muslimeen (AIMIM) on Monday announced a series of key organisational appointments, with Syed Abdul Hussain Anwar appointed as the party's new Ge... Read More
New Delhi, Sept. 28 -- The Supreme Court (SC) on Monday, September 28, refused to stay the Centre's decision to impose a Merchant Discount Rate (MDR) on specified Unified Payments Interface (UPI) pers... Read More
India, Sept. 28 -- It was the early 1950s. India, a young nation, was preparing for its first general election. The Constitution had given every adult the right to vote, regardless of gender, caste, w... Read More
India, Sept. 28 -- It was the early 1950s. India, a young nation, was preparing for its first general election. The Constitution had given every adult the right to vote, regardless of gender, caste, w... Read More
India, Sept. 28 -- NeOnc Technologies Holdings, Inc. (NTHI) announced that it is scheduled to meet with the U.S. Food and Drug Administration (FDA) on November 17, 2026, for an in-person End-of-Phase ... Read More
New Delhi, Sept. 28 -- Delhi Minister Parvesh Verma launched a scathing attack on the Aam Aadmi Party (AAP) on Monday over the "Slapgate" row, accusing the opposition of shielding criminals and runnin... Read More
New Delhi, Sept. 28 -- Escalating the political showdown over the Tilak Nagar slap controversy, Delhi Aam Aadmi Party (AAP) president Saurabh Bharadwaj, accompanied by party MLAs and councillors, reac... Read More
India, Sept. 28 -- Akeso, Inc. (9926.HK), a biopharmaceutical company, announced that it has enrolled the first patient in COMPASSION-37 (AK104-311), a phase 3 trial evaluating Cadonilimab as first-li... Read More